Arkolith/Insider Trading/SANA/Form 4

Wyrick Susan D.

See RemarksSana Biotechnology, Inc. (SANA) · full profile →Form 4 · filed Dec 5, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
4 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 4, 2025Tax withholding(F)3K$4.44$11K178K
Dec 3, 2025Option exercise(M)10K—$0181K
Jun 4, 2025Tax withholding(F)3K$2.32$6K168K
Jun 3, 2025Option exercise(M)10K—$0170K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 3, 2025Option exercise(M)10K—$00
Jun 3, 2025Option exercise(M)10K—$010K
Dec 13, 2024Grant(A)5K—$05K
Dec 13, 2024Grant(A)3K—$03K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001568605-25-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML